Univ8 Genomics
1 known investors
Find your way into Univ8 Genomics
Sign up to see every warm intro you have to Univ8 Genomics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Univ8 Genomics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Univ8 Genomics develops next-generation sequencing (NGS) assays that run on a single universal workflow to detect genetic alterations such as rearrangements, translocations, sequence variants and copy number changes across different cancer types. Its tests serve clinical and diagnostic laboratories performing cancer and hematologic malignancy testing.
Investors · 1
Frequently asked questions
- What does Univ8 Genomics do?
- Univ8 Genomics develops next-generation sequencing (NGS) assays that run on a single universal workflow to detect genetic alterations such as rearrangements, translocations, sequence variants and copy number changes across different cancer types. Its tests serve clinical and diagnostic laboratories performing cancer and hematologic malignancy testing.
- Who are Univ8 Genomics's investors?
- Univ8 Genomics's investors include QUBIS.